Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
Superinvestors holding TBPH, Q2 2026
No superinvestor reported holding TBPH in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of TBPH each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2024
0 superinvestors holding at quarter end
- Sold out
- Baupost Group
Q2 2024
1 superinvestor holding at quarter end
- Reduced
- Baupost Group (−36.3%)
Q1 2024
1 superinvestor holding at quarter end
- Reduced
- Baupost Group (−11.1%)
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- Baupost Group (−28.8%)
Q1 2023
1 superinvestor holding at quarter end
- Reduced
- Baupost Group (−8.8%)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- Baupost Group (−14.9%)
Q2 2022
1 superinvestor holding at quarter end
- Reduced
- Baupost Group (−1.6%)
Q1 2022
1 superinvestor holding at quarter end
- Reduced
- Baupost Group (−0.1%)
Q3 2021
1 superinvestor holding at quarter end
- Added
- Baupost Group (+37.8%)
Q2 2021
1 superinvestor holding at quarter end
- Added
- Baupost Group (+13.5%)